|Icone Imprimer

7 Canceropôles in France

for accelerating translational cancer research

Since 2003, the Cancéropôles have become part of the cancer research landscape in France enabling a better coordination of resources and means and breaking down barriers. They give rise to large-scale research networks and infrastructures fostering interdisciplinarity.

The 7 regional or interregionals hubs named Cancéropôles bring together research units of scientific institutions (INSERM, CNRS, universities, CEA,…), university hospitals, comprehensive cancer centers, pharmaceutical companies and biotech players.

Their goals are mainly:

  • structure and coordinate research between institutions at regional and inter-regional levels,
  • define specific strategic orientations based on the fields of excellence of each Cancéropôle,
  • create synergies with innovation and economic development stakeholders,
  • and ensure adequacy between regional and national R&D policies in oncology, as promoted by the French National Cancer Institute (INCa).


High-level quality research projects supported by the INCa through the Cancéropôles networks should allow the better understand the molecular mechanisms involved in oncogenesis which is crucial to define new therapeutic targets and to develop innovative treatments for the benefit of all patients.